Study Description

A multicenter, randomized, 15-22 week, double-blind, placebo-controlled research study to evaluate the effectiveness and safety of an investigational medication when taken at the same time as a marketed antidepressant in the treatment of subjects with Major Depressive Disorder.

Length of study: up to 22 weeks

Number of office visits: up to 14 visits

Qualified participants will receive study medication and study related services at no cost. In addition, participants will be reimbursed for time and travel.

Study inclusion/exclusion criteria

This study is only available to persons who:

• Read and understand English
• Meet criteria for Major Depressive Disorder
• Are 18 to 65 years old
• Have a history of inadequate response to past antidepressant treatment
• Are without serious health problems
• Do not have certain conditions such as Bipolar or Obsessive-Compulsive Disorder
• Are not addicted to drugs or alcohol

Contact us at:

California Neuroscience Research Medical Group, Inc.
4835 Van Nuys Blvd., Suite 104
Sherman Oaks, CA 91403 USA
(818) 990-2671
bahiye@cnrmg.com
alex@cnrmg.com
 

[Home] [For Patients] [Studies] [FAQ] [Sponsor Overview] [Contact Us]